Equifax Inc. executive Sunil Bindal, EVP and Chief Corporate Development Officer, reported equity transactions in company common stock. On February 10, 2026, he acquired 2,747 shares at $0.0000 per share as a grant or award, increasing his direct holdings.
On the same date, 1,727 shares were disposed of at $202.71 per share to satisfy tax obligations through share withholding. After these transactions, Bindal directly owned 8,656 common shares, including dividend equivalent units reinvested in corresponding restricted stock units.
Equifax Inc. CEO and director Mark W. Begor reported multiple equity transactions dated 02/10/2026. He exercised a stock option for 37,791 shares of common stock at an exercise price of $112.46 per share and received a separate grant of 33,278 common shares at $0.0000.
On the same day, he executed a series of open-market sales of common stock at weighted average prices ranging from $192.8855 to $203.0792 per share, including blocks such as 11,000 and 18,352 shares. A further 1,759 shares were withheld at $202.71 to cover tax obligations.
After these transactions, Begor directly held 230,506 common shares and maintained additional indirect holdings through several GRAT vehicles, including 10,500, 21,284, 22,045, 12,333, and 16,287 shares. The sales were carried out under a Rule 10b5-1 trading plan adopted on 10/28/2025.
Equifax Inc. executive Jamil Farshchi, EVP and Chief Technology Officer, reported multiple stock transactions. On 02/10/2026 he exercised a stock option for 6,213 shares of common stock at $191.44 per share and received an additional 4,667 common shares as a grant at $0.0000 per share. To cover obligations, 3,042 shares were withheld at $202.71 per share. On 02/10/2026 he sold 6,213 common shares at $195.81 per share, and on 02/11/2026 he sold 1,167 common shares at $199.87 per share. The sales were made under a Rule 10b5-1 trading plan adopted on 4/25/2025, and he held 39,869 common shares directly after the reported transactions.
A shareholder filed a notice of proposed sale of 2,535 common shares, with an aggregate market value of 485,452.50. The shares are planned to be sold on or about 02/12/2026 on the NYSE through Fidelity Brokerage Services LLC.
These shares were acquired on 05/06/2025 via restricted stock vesting from the issuer as compensation, with the same date listed as the payment date. The filing notes total shares outstanding of 122,394,037 for the same class of common stock.
Equifax insider Jamil Farshchi has filed a notice to sell company stock. The filing covers a planned sale of 1,167 shares of common stock on the NYSE through Fidelity Brokerage Services, with an approximate sale date of 02/11/2026 and an aggregate market value of 233,248.29.
The 1,167 shares were acquired on 02/10/2026 through restricted stock vesting as compensation from the issuer. The notice also shows that on 02/10/2026, Farshchi sold 6,213 common shares for gross proceeds of 1,216,567.53.
A person has filed a notice of proposed sale of 6,213 shares of common stock through Fidelity Brokerage Services LLC on the NYSE. The planned sale date is February 10, 2026, with an indicated aggregate market value of $1,216,567.53.
The securities were acquired on February 10, 2026 through an option that was originally granted on February 21, 2020, and the exercise price was paid in cash on the same acquisition date. The filing indicates total 122,394,037 shares of this class of common stock are outstanding.
A shareholder has filed a notice of intent to sell 37,791 shares of common stock through Fidelity Brokerage Services LLC, to be sold on the NYSE around 02/10/2026. The filing lists an aggregate market value of about $7,399,855.71 for these shares.
The shares were acquired as a stock option granted on 05/04/2018 and exercised for cash on 02/10/2026. The notice also reports that 122,394,037 shares of this class of stock are outstanding.
Equifax Inc. CEO and director Mark W. Begor reported equity transactions in company common stock dated February 3, 2026. He acquired 59,123 shares of common stock at $0.0000 per share and had 2,405 shares disposed of at $175.05 per share, leaving 198,987 shares directly owned.
The filing also lists indirect holdings in several grantor retained annuity trusts (GRATs), including 10,500, 21,284, 22,045, 12,333 and 16,287 shares of common stock. A footnote explains that the reported direct holdings include accrued dividend equivalent units and 199 shares purchased under the Equifax Inc. 2020 Employee Stock Purchase Plan.
Equifax Inc. filed a current report to note that it has released its financial results for the three- and twelve-month periods ended December 31, 2025. The company issued a press release on February 4, 2026, and attached the full text as an exhibit to this report.
The press release, included as Exhibit 99.1, is designated as “furnished” rather than “filed” under securities law, which affects how it is treated for certain liability and incorporation-by-reference purposes. No specific revenue, profit, or other financial figures are detailed in this report itself.
Equifax Inc. CEO and director Form 4 filing details insider share activity. On 12/31/2025, a reporting person had 997 shares of Equifax common stock withheld in a transaction coded "F" at a price of $216.98 per share, typically indicating shares withheld to cover taxes on equity awards. After this transaction, the insider directly beneficially owned 142,091 shares of common stock. The insider also held additional indirect interests through several grantor retained annuity trusts (GRATs), including 10,500 shares in a 2-year 2025 GRAT, 21,284 shares in a 2-year December 2025 GRAT, 22,045 shares in a 2-year June 2025 GRAT, 12,333 shares in a 2-year May 2025 GRAT, and 16,287 shares in a 3-year July 2024 GRAT. The holdings include accrued dividend equivalent units and 199 shares purchased under the Equifax Inc. 2020 Employee Stock Purchase Plan.